The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sairenji, 2017, An update on inflammatory bowel disease, Prim Care, 44, 673, 10.1016/j.pop.2017.07.010
Baumgart, 2007, Inflammatory bowel disease: cause and immunobiology, Lancet, 369, 1627, 10.1016/S0140-6736(07)60750-8
Ng, 2018, Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies, Lancet, 390, 2769, 10.1016/S0140-6736(17)32448-0
Yang, 2017, How does the epidemiology of inflammatory bowel disease differ between east and west? A Korean perspective, Inflamm Intest Dis, 2, 95, 10.1159/000454712
2018, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1736, 10.1016/S0140-6736(18)32203-7
2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7
Tontini, 2015, Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives, World J Gastroenterol, 21, 21, 10.3748/wjg.v21.i1.21
2017, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1211, 10.1016/S0140-6736(17)32154-2
2018, Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1995, 10.1016/S0140-6736(18)32278-5
Malik, 2015, Inflammatory bowel disease: historical perspective, epidemiology, and risk factors, Surg Clin North Am, 95, 1105, 10.1016/j.suc.2015.07.006
Loftus, 2016, Update on the incidence and prevalence of inflammatory bowel disease in the United States, Gastroenterol Hepatol, 12, 704
Stone, 2003, Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England, Eur J Gastroenterol Hepatol, 15, 1275, 10.1097/00042737-200312000-00004
Binder, 2004, Epidemiology of IBD during the twentieth century: an integrated view, Best Pract Res Clin Gastroenterol, 18, 463, 10.1016/j.bpg.2003.12.002
Economou, 2008, New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations, Inflamm Bowel Dis, 14, 709, 10.1002/ibd.20352
Kaplan, 2015, The global burden of IBD: from 2015 to 2025, Nat Rev Gastroenterol Hepatol, 12, 720, 10.1038/nrgastro.2015.150
Bernstein, 2001, The relationship between inflammatory bowel disease and socioeconomic variables, Am J Gastroenterol, 96, 2117, 10.1111/j.1572-0241.2001.03946.x
Alexander, 2014, Microbiota activation and regulation of innate and adaptive immunity, Immunol Rev, 260, 206, 10.1111/imr.12180
Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009
Lovasz, 2013, New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe, Dig Liver Dis, 45, 269, 10.1016/j.dld.2012.08.020
Shouval, 2017, The role of environmental factors in the pathogenesis of inflammatory bowel diseases: a review, JAMA Pediatr, 171, 999, 10.1001/jamapediatrics.2017.2571
Abegunde, 2016, Environmental risk factors for inflammatory bowel diseases: Evidence based literature review, World J Gastroenterol, 22, 6296, 10.3748/wjg.v22.i27.6296
Rogler, 2012, Role of biological therapy for inflammatory bowel disease in developing countries, Gut, 61, 706, 10.1136/gutjnl-2011-300613
Burisch, 2013, The burden of inflammatory bowel disease in Europe, J Crohns Colitis, 7, 322, 10.1016/j.crohns.2013.01.010
Kawalec, 2016, Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review, Arch Med Sci, 12, 295, 10.5114/aoms.2016.59254
Dignass, 2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management, J Crohns Colitis, 6, 991, 10.1016/j.crohns.2012.09.002
Dignass, 2010, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management, J Crohns Colitis, 4, 28, 10.1016/j.crohns.2009.12.002
Mikocka-Walus, 2016, Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease, Clin Gastroenterol Hepatol, 14, 829, 10.1016/j.cgh.2015.12.045
M'Koma, 2013, Inflammatory bowel disease: an expanding global health problem, Clin Med Insights Gastroenterol, 6, 33, 10.4137/CGast.S12731
Law, 2014, Gender-related differences in clinical course of crohn's disease in an Asian population: a retrospective cohort review, Arq Gastroenterol, 51, 90, 10.1590/S0004-28032014000200004
Sood, 2003, Incidence and prevalence of ulcerative colitis in Punjab, North India, Gut, 52, 1587, 10.1136/gut.52.11.1587
Khosla, 1986, Epidemiology of ulcerative colitis in hospital and select general population of northern India, J Assoc Physicians India, 34, 405
Ghoshal, 2017, Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population, J Gastroenterol Hepatol, 32, 378, 10.1111/jgh.13465